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Abstract
Background: Avipoxvirus sp. is a significant threat to endemic bird populations on several groups of islands worldwide,
including Hawai`i, the Galapagos Islands, and the Canary Islands. Accurate identification and genotyping of Avipoxvirus is
critical to the study of this disease and how it interacts with other pathogens, but currently available methods rely on
invasive sampling of pox-like lesions and may be especially harmful in smaller birds.
Methodology/Principal Findings: Here, we present a nested TaqMan Real-Time PCR for the detection of the Avipoxvirus 4b
core protein gene in archived blood samples from Hawaiian birds. The method was successful in amplifying Avipoxvirus
DNA from packed blood cells of one of seven Hawaiian honeycreepers with confirmed Avipoxvirus infections and 13 of 28
Hawai`i `amakihi (Hemignathus virens) with suspected Avipoxvirus infections based on the presence of pox-like lesions. Mixed
genotype infections have not previously been documented in Hawai`i but were observed in two individuals in this study.
Conclusions/Significance: We anticipate that this method will be applicable to other closely related strains of Avipoxvirus
and will become an important and useful tool in global studies of the epidemiology of Avipoxvirus.
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Introduction
Avian pox virus (Avipoxvirus sp.) has caused extensive morbidity
and mortality in the native Hawaiian avifauna [1,2] and currently
threatens endemic birds in the Galapagos and Canary Islands
[3–6]. The virus is mechanically transmitted on the mouthparts of
blood or tissue feeding arthropods or by entry through cuts or
breaks in the skin. Two types of disease have been described –
localized cutaneous lesions at the site of viral entry and a
disseminated diphtheritic form of infection where the virus spreads
on mucous membranes of the mouth, esophagus, and upper
digestive tract. Lesions can lead to blindness when they occur
around the eyes, can obstruct feeding or breathing when they
occur around the mouth or in the esophagus, can interfere with
perching when they occur on the feet or legs, and frequently lead
to development of secondary bacterial infections [7]. Early
Hawaiian bird extinctions of the mid to late 1800’s have been
attributed to avian pox [2], and the virus may be contributing
significantly to the continued decline of some populations. Two
variants of the virus have been reported in native and non-native
birds in the Hawaiian Islands. They differ in virulence, and have
been shown to cause mortality among naı ¨ve Hawai`i `amakihi
(Hemignathus virens), hereafter`amakihi, under experimental condi-
tions [8]. One of these variants has been shown to have a very
close phylogenetic relationship with canarypox, as have Avipoxvirus
variants present in the Galapagos Islands [4]. In the Hawaiian
Islands, co-infections of avian malaria (Plasmodium relictum) and
Avipoxvirus in natural populations of forest birds is common and
more frequent than expected by chance alone [9,10]. Given the
potential immunocompromising capabilities of pox viruses
[11,12], co-infection with Plasmodium may result in increased
severity of acute malarial infections and recrudescence of chronic
infections, with potential influences on both virulence and
transmission of both pathogens.
The gold standard for diagnosing infection with Avipoxvirus
continues to be both isolation of live virus and demonstration of
the characteristic viral inclusion bodies (i.e. Bollinger Bodies) in
fixed and stained sections of lesions that are typically collected at
necropsy. Neither of these methods is effective in field studies of
wild avian populations because the viral inclusion bodies typically
occur in the dermis and are thus inaccessible to non-invasive
sampling methods. While biopsy of these highly vascularized
lesions under field conditions is possible, it is difficult in small
passerines, where creation of an open wound may lead to
subsequent secondary bacterial infections. As a result, most field
studies of Avipoxvirus rely on presumptive diagnoses of lesions that
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10745are not able to differentiate viral infection from swellings that may
be caused by knemidokoptic skin mites, bacterial infection, or
mechanical injuries.
The relatively recent introduction of a highly efficient mosquito
vector (Culex quinquefasciatus) and two avian pathogens (P. relictum
and Avipoxvirus) to Hawai`i’s isolated island ecosystem with naı ¨ve,
highly susceptible avian hosts provides unique opportunities to
investigate host-parasite-parasite co-evolution in a natural disease
system. Development of an effective method for safely confirming
and genotyping infection with Avipoxvirus in both avian hosts and
arthropod vectors is critical for forming a better understanding of
the population level impacts of this disease and how it interacts
with other pathogens. Here, we describe a nested TaqMan Real-
Time PCR method for the detection of Avipoxvirus in archived
blood samples of Hawaiian birds with applications toward
population-level analyses.
Results
The results from a Taqman Real-Time PCR completed on a
serial dilution of first reaction products from a known positive
sample (pox culture lysate from Variant 2, Hawai`i `iamakihi 15;
[8]) are shown in Figure 1 and Table 1. In real-time diagnostic
assays, a positive or negative result is often determined by the cycle
number at which signal from a sample crosses a baseline threshold
(Ct). Ct values for the serial dilution ranged from 13.9 to 22.7 with
the differences between Ct values shown in Table 1. The dilution
series shows Ct differences ranging from 0.7 to 1.6, which is close
to the expected 1.0 cycle increase expected in a 1:2 dilution series
as the concentration of the target decreases [13].
We evaluated a total of 36 frozen packed blood cell samples and
22 corresponding plasma samples from wild Hawaiian honey-
creepers. Seven of these samples represent known Avipoxvirus
infections and were collected on the islands of Hawai`i and Moloka`i
between 2002 and 2009 from three species of honeycreepers:
`amakihi (n=3), `apapane (Himatione sanguinea, n=3), and i`iwi
(Vestiaria coccinea, n=1). Infections in these birds were confirmed
either by successful culturing of Avipoxvirus or positive PCR
screening of lesion samples taken at the time of blood sample
collection. We evaluated plasma samples from four of these seven
birds. In addition, we evaluated 29 frozen packed cell samples
collected from wild `amakihi on the island of Hawai`ib e t w e e n
2002 and 2005 [10,14]. All 29 of these birds had pox-like, smooth
or scabby swellings on the feet or legs at the time of capture.
Plasma samples collected from 18 of these 29 birds were also
evaluated. Gel electrophoresis of products from the first reaction
using packed cell samples (primers P1 [15] and PV4B.P5 [8])
revealed a band at approximately 450 bp in all but one
individual, corresponding to the expected fragment size for
Avipoxvirus product. Sequencing of a small number of these bands
(n=4) revealed that the bands do not represent the Avipoxvirus 4b
core protein gene, but instead appear to originate from the avian
host. The 450 bp band was not detected in any of the 22 plasma
samples analyzed. Because these bands appeared in at least one
first reaction for all known infected packed cell samples and 28 of
29 unknown packed cell samples, they served as an internal
reference for the quality of each template DNA as well as the
success of the first reaction. The one bird for which no first
reaction band was observed in any of the three repeat reactions
was considered to be a poor quality template and was removed
from further consideration.
The nested TaqMan PCR amplified Avipoxvirus DNA from one
out of seven packed cell samples from known pox-infected birds in
three separate PCR reactions (Table 2). This sample (HAAM 26.1)
produced a clear positive result in all reactions and was included as
a positive control in reactions with unknown samples as well. The
method presented here also amplified Avipoxvirus DNA from 13 of
28 packed cell samples of `amakihi with presumed but not
confirmed pox infections (Table 3). In two of these 13`amakihi,
Avipoxvirus DNA was detected in all reactions. Three other
Figure 1. Real-time amplification of a serially diluted known positive sample. PCR base line subtracted curve fit data shows amplification of
the Avipoxvirus 4b core protein gene from a 1:2 serial dilution of first reaction PCR product using gDNA from Avipoxvirus culture lysate as template.
The threshold for this reaction was 79.0 rfu.
doi:10.1371/journal.pone.0010745.g001
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two of three reactions, and an additional three `amakihi were
successful in one of two reactions. Successful amplification in only
one of three reactions was observed in five`amakihi, while no
successful amplification of Avipoxvirus DNA occurred in the
remaining 15 `amakihi (1–3 successful first reactions per individ-
ual). Avipoxvirus DNA was not detected in plasma samples from
four known infected samples and 18 samples with unconfirmed
infections. Amplification was not detected for negative controls in
any of the reactions, nor was any other sign of contamination
observed. Bands from 11 of the PCR-positive birds (packed cell
samples) were gel purified and sequenced, and all sequences were
identified as the expected portion of the Avipoxvirus 4b core protein
gene (Table 3). One bird was infected with variant 1, while eight
individuals were infected with variant 2 [8]. Interestingly, two
additional birds were infected with both variants based on the
presence of numerous mixed peaks in the chromatograph at
Table 2. Ct values and final intensities from triplicate nested
TaqMan Real-Time PCR reactions for packed cell samples from
wild honeycreepers with confirmed Avipoxvirus infections.
Sample ID
1 Ct
final
RFU Ct
final
RFU Ct
final
RFU
HAAM 28.1 HI 2003 35.1 56.14 N/A 34.11 45.5 64.47
IIWI 3.1 HI 2003 45.8 29.87 49.6 49.45 N/A 41.32
HAAM 26.1 HI 2005 NR
3 NR 18.7 748.04 17.2 661.42
APAP 14.1 MO 2003
2 37.9 53.66 N/A 33.30 49.3 44.28
HAAM 15.4 HI 2003
2 – – N/A 46.02 N/A 31.64
APAP 16.1 HI 2003
2 – – N/A 25.10 N/A 42.52
APAP 30.1 HI 2009 – – N/A 29.23 46.1 53.55
lysate (+) 14.2 1014.76 16.9 925.04 16.1 830.80
dH2O (2) 32.8 204.22 45.6 74.06 49.5 46.07
dH2O (2) 30.3 90.75 45.6 75.01 49.7 45.19
Successful amplifications (Ct,25 and final RFU.425) are indicated in bold.A l l
values are based on PCR Base Line Subtracted Curve Fit Data as calculated using
iCycler version 3.1 software (BioRad). The threshold intensity was 23.4 rfu for the
first reaction, 51.4 rfu for the second reaction, and 41.7 rfu for the third reaction.
1Samples are identified by species, island and year of capture. Abbreviations are
as follows: HAAM, Hawai`i `amakihi (Hemignathus virens); IIWI, i`iwi (Vestiaria
coccinea); APAP, `apapane (Himatione sanguinea); HI, Hawai`i; MO, Moloka`i.
2Laboratory Avipoxvirus isolates cultured from these individuals are included in
Jarvi, et al., 2008 [8].
3NR indicates the sample was not included in that reaction, a dash (2) indicates
a failed first reaction and potential false negative, N/A indicates that no Ct
value was assigned because the signal for the sample never reached the
threshold intensity for that reaction.
doi:10.1371/journal.pone.0010745.t002
Table 1. Ct values, Ct differences between dilutions, and final
intensities for serial dilution of first reaction products from
Avipoxvirus culture lysate.
Sample dilution
Ct Value
(cycles)
Ct Difference
(cycles) Final RFU
2.0610
24 13.9 -- 825.81
1.0610
24 15.2 1.3 781.28
5.0610
25 15.9 0.7 694.47
2.5610
25 17.3 1.4 652.49
1.25610
25 18.1 0.8 594.54
6.25610
26 18.9 0.8 702.34
3.12610
26 20.5 1.6 616.03
1.56610
26 21.7 1.2 681.56
7.81610
27 22.7 1.0 606.69
doi:10.1371/journal.pone.0010745.t001
Table 3. Ct values, final intensities and sequencing results
from triplicate nested TaqMan Real-Time PCR reactions for
packed cell samples from wild`amakihi with presumptive pox
lesions.
Ct
final
RFU Ct
final
RFU Ct
final
RFU
Avipoxvirus
variant
2
6779 N/A 21.77 N/A 47.9 49.4 13.12
7216 –
1 – 50.8 54.99 49.9 14.63
7379 18.1 647.43 18.2 764.55 14.8 624.27 2
7396 N/A 28.85 – – 49.5 13.83
7596 – – 44.9 61.56 34.2 115.39
8495 25.7 98.83 N/A 24.54 49 14.88
10232 – – – – 50.1 8.68
10291 23.8 441.35 36.7 396.51 1.7 9.22 2
10302 18.9 762.18 45.8 57.83 33.5 48.41 2
10332 23 628.95 N/A 36.45 45.2 22.2 NS
10342 – – – – 37.5 276.06
10588 20.4 584.71 38.3 76.88 44.4 29.04 2
10630 N/A 22.08 N/A 42.87 34.7 38.88
10643 17.4 751.9 – – 42.7 45.71 2
10652 N/A 10.11 N/A 4.49 49.5 14.46
10716 19.1 696.3 43.6 66.56 – – 2
11350 43.1 46.76 N/A 36.22 45.8 20.84
11408 – – 24.3 692.91 15.4 596.31 2
11458 22.4 707.45 39.2 75.03 16.3 486.49 2
12657 23.1 430.5 22.3 742.46 28.5 40.31 NS
12717 22 647.68 39.8 74.78 20.6 497.12 1,2
12818 N/A 24.08 48.7 54.75 45.2 25.04
12847 49.8 40.76 42.8 74.77 46 19
12858 N/A 24.86 45.8 61.09 17.1 567.41 NS
13916 – – 21.9 557.07 N/A 21.13 1
16562 N/A 8.18 45.3 59.42 49.5 9.48
16922 42 52.16 – – 45.8 16.7
17331 N/A 25.82 40 69.97 48.3 23.75
HAAM 26.1 19.7 815.81 17.9 854.29 14 667.18 1,2
lysate (+) 18.2 731.57 16.3 825.46 13.9 602.86 2
dH2O (2) N/A 3.98 N/A 37.13 49.6 20.37
dH2O (2) N/A 1.02 40.7 78.88 49.9 11.17
Successful amplifications (Ct,25 and final RFU.425) are indicated in bold.A l l
values are based on PCR Base Line Subtracted Curve Fit Data as calculated using
iCycler version 3.1 software (BioRad). The threshold intensity was 37.0 rfu for the
first reaction, 48.3 rfu for the second reaction, and 10.8 rfu for the third reaction.
1A dash (2) indicates a failed first reaction and potential false negative, N/A
indicates that no Ct value was assigned because the signal for the sample
never reached the threshold intensity for that reaction.
2Variant numbers correspond to Avipoxvirus clusters 1 and 2 as previously
described [8]; NS indicates not sequenced.
doi:10.1371/journal.pone.0010745.t003
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between the variants.
Discussion
We present here a successful method for amplifying the 4b core
protein gene of Avipoxvirus from archived field blood samples. This
method detected Avipoxvirus DNA in one of seven wild honey-
creepers with confirmed Avipoxvirus infections and in 13 of 28 wild
`amakihi with pox-like lesions. The rate of detection of Avipoxvirus
DNA in blood samples from birds with confirmed infection was
disappointingly low. This procedure is therefore not a useful
diagnostic when applied alone; however, it can provide confirma-
tion of a presumptive diagnosis based on the presence of pox-like
lesions when amplification is successful. Perhaps more important-
ly, this nested TaqMan Real-Time PCR provides a method for
genetic characterization and confirmation of suspected pox
infections that would not otherwise be available from archived
field samples.
Prior to the development and application of this technique, it
was unknown whether such archived samples could be used for the
study of Avipoxvirus in wild populations of birds. Relatively little is
known about the life cycle of Avipoxvirus in hosts other than
domestic poultry, and it is possible that the virus may not always
be present in the blood of apparently infected birds or may be
present at titers below the detection limit of this method. Fowlpox,
one of 10 currently recognized species of Avipoxvirus, has been
detected by live virus isolation in the buffy coat portion of the
blood of intravenously infected chickens [16], as well as by real-
time PCR in the buffy coat of one of nine chickens infected via
wing web inoculation [17]. However, most PCR-based studies of
fowlpox virus and other Avipoxvirus species continue to rely on
lesion scrapings or biopsies as a source of template DNA [4,18].
To our knowledge, this is the first protocol to successfully amplify
Avipoxvirus from the blood of naturally infected, wild passerines.
Real-time methods have had mixed success in detecting other
orthopoxvirus species in blood, with one group reporting
successful detection of mouse pox virus in the spleen and lung
but not blood of experimentally infected mice [19] and another
group reporting relatively high rates of detection of monkeypox
virus DNA in the blood of experimentally infected monkeys [20].
Other studies have demonstrated very low rates of detection of
vaccinia virus DNA in the blood of individuals recently vaccinated
for smallpox [21,22]. One of the few studies applying real-time
diagnostics to blood samples from natural infections reported
successful amplification of bovine vaccinia from a single human
blood sample [23]. Most successful amplification of pox virus
DNA from blood samples of experimentally infected animals or
vaccinated humans are within 11–21 days post infection [20,21],
suggesting that the presence of viral DNA in the host bloodstream
may be of limited duration. Our lack of detection in plasma
samples and low rate of detection in packed cell samples from
known infections agree with these studies and is most likely a result
of the lack of viremia at various time points during infection.
From the 28 Hawai`i `amakihi with a presumptive diagnosis of
avian pox included in this study, we were able to amplify pox in at
least one of three reactions from 13 birds. This detection rate is
slightly higher than that observed in`amakihi with confirmed
Avipoxvirus infections (1/3) and much higher than observed in
known infected `apapane (0/3) and i`iwi (0/1). While sample sizes
are too low to draw any firm conclusions, further investigation of
species-specific differences in detectability of Avipoxvirus infection
that may reflect both magnitude and duration of viremia in
different avian hosts appear warranted.
Of the 13 `amakihi from which Avipoxvirus DNA was successfully
amplified, eight individuals were positive in only one reaction.
While this could be explained as contamination, methods for
controlling contamination were rigorously followed and no signs of
contamination were observed in negative control samples.
Furthermore, levels of target DNA close to the detection limit of
a method have been shown to produce inconsistent real-time
results [24,25]. We therefore conclude that a lack of amplification
in repeat reactions for these samples is most likely due to low titer
viremia in the blood of these individuals. Future applications of
this method may be improved by the use of viral-enriching
extraction techniques [26].
Failure to amplify pox DNA from the remaining 15 of 28 wild
`amakihi could be because the virus is not present in the blood of
these birds or may be present in very low titers. Alternatively, the
initial presumptive diagnosis of Avipoxvirus infection based only on
the presence of tumor-like lesions or swelling may have been
incorrect. Pox-like lesions or scars can be caused by injury,
infestation with knemidokoptic skin mites, and/or secondary
bacterial infections, and are not always confirmed by more
stringent methods [2].
In a previous study of cultured Avipoxvirus isolates from Hawai`i,
4b core protein gene sequences sorted equally into one of two
clusters that were designated variant 1 and variant 2 [8]. In
contrast, the majority of the wild infections confirmed in the
current study were identified as variant 2. Experimental studies
indicate that variant 2 is more virulent in`amakihi, producing
larger, more proliferative lesions than variant 1 [8]. Interestingly, a
loss of virulence has been linked to lower viremia in sheeppox virus
[27]. Therefore, it is possible that the higher rate of detection of
variant 2 in this study is due to the production of higher viremias
by the more virulent variant.
The detection of two individuals infected with a mix of
Avipoxvirus variants 1 and 2 was unexpected given the lack of
detection of genetically mixed infections in the limited number of
lesion samples in a previous study [8]. This may be an indication
that simultaneous Avipoxvirus infections are more readily detected
in blood samples than from lesion biopsies, particularly if viral
genotypes are segregated by lesion and missed during biopsy. This
has important implications for how lesions are sampled for
diagnosis and genotyping and for our understanding of their
pathogenesis. Our detection of mixed genotype Avipoxvirus
infections in two`amakihi also suggests that simultaneous infections
may be more common than anticipated and highlights an
additional source of complexity in the transmission of these
diseases in Hawai`i. Population level studies will be required to
determine the distribution of each variant and the extent of co-
infection between pox variants and between Avipoxvirus and avian
malaria as well. To that end, this new non-invasive method to
confirm and genotype Avipoxvirus infections should prove a useful
and highly informative tool. Because of the close relationship of
Hawaiian Avipoxvirus and Galapagos Avipoxvirus to canarypox [4,8],
we anticipate that the primers, probe and method described here
will also be applicable to other avian populations with only minor
modifications and thus may be a useful tool in global studies of the
epidemiology of Avipoxvirus.
Materials and Methods
Sample Collection
Collection of field samples was approved by the University of
Hawai`i Institutional Animal Care and Use Committee, protocol
00–035. Blood samples were collected by jugular venipuncture
with heparinized 26 gauge insulin syringes from 29 wild `amakihi
Avipoxvirus Real-Time PCR
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lesions. These blood samples were obtained on the Eastern slope of
Mauna Loa and Kilauea Volcanoes on the island of Hawai`ia s
part of a larger study of the transmission of avian malaria and pox
virus in native and non-native forest birds (NSF Biocomplexity of
Introduced Avian Diseases in Hawai`i; [14]). Birds were mist-
netted, banded, bled and released. Immediately after blood was
drawn, it was transferred to heparinized microhematocrit tubes
and centrifuged with a battery-operated field centrifuge to separate
plasma from cells. The microhematocrit tube was scored with a file
and broken just above the boundary of the buffy coat and plasma,
and plasma was transferred to an empty, sterile 0.5 ml vial before
freezing. Packed lymphocytes and erythrocytes were removed with
a filter-tipped pipetter, transferred to an equal volume of lysis
buffer (2% sodium dodecyl sulfate, 0.1 M EDTA, 0.1 M Tris,
pH 8.0) in a sterile 0.5 ml vial and frozen. These samples are
referred to as ‘‘packed cells’’ throughout and contain packed red
blood cells and a portion of the buffy coat.
Blood samples and tissue samples from pox-like lesions were also
obtained from an additional three wild `amakihi, one wild i`iwi,
and three wild `apapane. Avipoxvirus infection in six of these birds
was confirmed by live virus isolation and propagation as previously
described [8]. Avipoxvirus infection in the seventh bird (APAP 30.1)
was confirmed using the real-time method described here.
Samples and DNA extraction
DNA was extracted from pox culture lysate as previously
described (Variant 2, Hawai`i `amakihi 15; [8]) for use as a positive
control in all reactions. DNA was extracted from packed cells and
a single lesion tissue sample using the Qiagen DNeasy Animal
Tissue Kit following manufacturer’s protocols. Blood samples were
stored in lysis buffer at 280uC for up to three years prior to DNA
extraction; genomic DNA was stored at 280uC for as many as
eight additional years prior to real-time PCR analysis. ‘‘Blank’’
samples containing no tissues were included in extractions and
carried through subsequent steps to monitor for contamination.
PCR Amplification of Avipoxvirus DNA
A nested PCR approach was used to amplify a portion of the
Avipoxvirus 4b core protein gene. In the first reaction, 1 mlo fg e n o m i c
DNA from field samples or pox culture lysate, or 1 mlo fu n e x t r a c t e d
plasma, was used as template in 25 ml reactions containing 1X PCR
buffer, 1.5 mMMgCl2,2 0 0mMeachdNTP,0.4 mM each of primers
P1 [15] and PV4B.P5 [8], and 1.25 units GoTaq Flexi (Promega,
Madison, WI, USA). Reactions were subjected to an initial
denaturing period of 2 minutes at 96uC, followed by 55 cycles of
96uCf o r1m i n u t e ,5 2 uCf o r1m i n u t e ,a n d7 2 uC for 1 minute, with a
final extension step of 7 minutes at 72uC. Products from the initial
PCR were diluted 1:80,000 in water and 1 ml of dilution was used as
template in a TaqMan real-time PCR assay. Primer 1F (59-TCC
TTG TAA AAG CGA TAC AGG AA-39)a n dp r i m e r1 R( 5 9-CCC
CTT AAC ATG TGC TAA CAA-39) produce a 234 bp fragment
within which lies the Pox1 probe (59-/56-FAM/CAG CGT GAT
GAA GAC GCT AA/3BHQ_1/-39), which is dual labeled with a 59-
56-FAM reporter and a 39-Black Hole Quencher (Integrated DNA
Technologies, Coralville, IA, USA). The real-time PCR assays were
run as 50 ml reactions containing 0.4 mM primer 1F, 0.4 mM primer
1R, 0.4 mM Pox1 probe and 25 mli QS u p e r m i x( B i o R a d ,H e r c u l e s ,
CA, USA). Reactions were run on a BioRad iCycler thermal cycler
equipped with an iQ Multi-Color Real-Time PCR detection system
(BioRad) using a 3 step PCR method consisting of an initial
denaturation step at 95uC for 3 minutes, followed by 55 cycles of
95uCfor30seconds,55uC for 15 seconds,and 63.3uCfor30seconds.
Reactions for packed cell samples were repeated in three separate
reactions, with samples run in a different random order each time;
reactions for plasma samples were run once. Precautions to reduce
and prevent contamination were taken during set-up of all reactions
and included the use of a CloneZone PCR workstation (USA
Scientific, Ocala, FL, USA) that was cleaned with sodium
hypochlorite solution and subjected to a minimum of 15 minutes
UV irradiation between reactions. Negative controls (water instead of
template DNA) were included in all reactions, and all reactions were
run in individual 0.2 ml tubes with attached optical dome cap
(BioRad). Data was analyzed using the PCR Base Line Subtracted
Curve Fit function of iCycler version 3.1 software (BioRad).
Successful amplification of the target Avipoxvirus 4b core protein gene
was determined based on Ct values below 25 and final signal
intensities above 425 rfu. In addition to collecting real-time
information during the run, products of both PCRs were analyzed
by electrophoresis on 1.5% agarose gels (SeaKem, Lonza, Switzer-
land) stained with ethidium bromide. In order to evaluate the real-
time assay and to determine the best dilution value between the first
and second reaction, a 1:2 serial dilution (2.0610
24 to 7.81610
27)o f
PCR product from the first reaction positive control (pox culture
lysate) was prepared and run using the real-time conditions described
above.
Sequencing of PCR Products
To confirm the amplification of Avipoxvirus DNA in the real-time
assay and to determine the identity of observed bands in the initial
reaction, PCR products were purified via gel excision. Products
were run on a 2% low-melt agarose gel (Fisher Scientific,
Pittsburgh, PA, USA) and bands of interest were excised and
purified following the manufacturer’s protocol using the QIAquick
Gel Extraction Kit (Qiagen, Valencia, CA, USA) with the final
elution in 30 ml Buffer EB. Purified PCR products were direct
sequenced in both directions using the appropriate PCR primers
(ASGPB, University of Hawai`i at Manoa). Resulting sequences
were hand corrected and aligned using Sequencher v. 4.2
(GeneCodes Corporation, Ann Arbor, MI, USA) and identified
via BLAST search on GenBank. All sequences are available in
GenBank under accession numbers GU982265 – GU982280.
Acknowledgments
We thank Pat Hart, Bethany Woodworth, Erik Tweed, Carlie Henneman,
Jaymi LeBrun, Tami Denette, and field interns of the Biocomplexity of
Avian Diseases Project for collecting blood samples from wild`amakihi. Any
use of trade, product, or firm names in this publication is for descriptive
purposes only and does not imply endorsement by the U.S. Government.
Its contents are solely the responsibility of the authors and do not
necessarily represent the official views of the funding agencies.
Author Contributions
Conceived and designed the experiments: MEMF DL RS SIJ. Performed
the experiments: MEMF CC RS. Analyzed the data: MEMF SIJ.
Contributed reagents/materials/analysis tools: DL CTA. Wrote the paper:
MEMF DL CTA SIJ.
References
1. Warner RE (1968) The role of introduced diseases in the extinction of the
endemic Hawaiian avifauna. Condor 70: 101–120.
2. van Riper III C, van Riper SG, Hansen WR (2002) Epizootiology and effect of
avian pox on Hawaiian forest birds. Auk 119: 929–942.
Avipoxvirus Real-Time PCR
PLoS ONE | www.plosone.org 5 May 2010 | Volume 5 | Issue 5 | e107453. Vargas H (1987) Frequency and effect of pox-like lesions in Galapagos
mockingbirds. J Field Ornithol 58: 101–102.
4. Thiel T, Whiteman NK, Tirape A, Baquero MI, Cedeno V, et al. (2005)
Characterization of canarypox-like viruses infecting endemic birds in the
Galapagos Islands. J Wildlife Dis 41: 342–353.
5. Kleindorfer S, Dudaniec RY (2006) Increasing prevalence of avian poxvirus in
Darwin’s finches and its effect on male pairing success. J Avian Biol 37: 60–76.
6. Smits J, Tella JL, Carrete M, Serrano D, Lo ´pez G (2005) An epizootic of avian
pox in endemic short-toed larks (Calandrella rufescens) and Berthelot’s pipits (Anthus
berthelotti) in the Canary Islands, Spain. Vet Path 42: 59–65.
7. van Riper III C, Forrester DJ (2007) Avian pox. In: Thomas N, Hunter B,
Atkinson CT, eds. Infectious diseases of wild birds, Ames, IA, Blackwell
Publishing. pp 131–176.
8. Jarvi SI, Triglia D, Giannoulis A, Farias M, Bianchi K, et al. (2008) Diversity,
origins and virulence of Avipoxviruses in Hawaiian Forest Birds. Conserv Genet
9: 338–348.
9. van Riper III C, van Riper SG, Goff ML, Laird M (1986) The epizootiology and
ecological significance of malaria in Hawaiian land birds. Ecol Monogr 56:
327–344.
10. Atkinson CT, Dusek RJ, Lease JK, Samuel MD (2005) Prevalence of pox-like
lesions and malaria in forest bird communities on leeward Mauna Loa Volcano,
Hawai`i. Condor 107: 537–546.
11. Buller RML, Palumbo GJ (1991) Poxvirus pathogenesis. Microbiol Rev 55:
80–122.
12. Smith SA, Kotwal GJ (2002) Immune response to poxvirus infections in various
animals. Crit Rev Microbiol 28: 149–185.
13. Kubista M, Andrade JM, Begtsson M, Forootan A, Jonak J, et al. (2006) The
real-time polymerase chain reaction. Mol Aspects of Med 27: 95–125.
14. Woodworth BL, Atkinson CT, LaPointe DA, Hart PJ, Spiegel CS, et al. (2005)
Host population persistence in the face of introduced vector-borne diseases:
Hawai`i` `amakihi and avian malaria. Proc Natl Acad Sci U S A 102: 1531–1536.
15. Lee LH, Lee KH (1997) Application of the polymerase chain reaction for the
diagnosis of fowl poxvirus infection. J of Virol Methods 63: 113–119.
16. Minbay A, Kreier JP (1973) An experimental study of the pathogenesis of
fowlpox infection in chickens. Avian Dis 17: 532–539.
17. Hauck R, Prusas C, Hafez HM, Lu ¨schow D (2009) Serologic response against
fowl poxvirus and reticuloendotheliosis virus after experimental and natural
infections of chickens with fowl poxvirus. Avian Dis 53: 205–210.
18. Tadese T, Fitzgerald S, Reed WM (2008) Detection and differentiation of re-
emerging fowlpox virus (FWPV) strains carrying integrated reticuloendotheliosis
virus (FWPV-REV) by real-time PCR. Vet Microbiol 127: 39–49.
19. Scaramozzino N, Ferrier-Rembert A, Favier AL, Rothlisberger C, Richard S,
et al. (2007) Real-time PCR to identify variola virus or other human pathogenic
orthopox viruses. Clin Chem 53: 606–613.
20. Saijo M, Yasushi A, Suzaki Y, Nagata N, Iwata N, et al. (2008) Diagnosis and
assessment of monkeypox virus (MPXV) infection by quantitative PCR assay:
differentiation of Congo Basin and West African MPXV strains. Jpn J Infect Dis
61: 140–142.
21. Cohen JI, Hohman P, Preuss JC, Li L, Fischer SH, Fedorko DP (2007)
Detection of vaccinia virus DNA, but not infectious virus, in the blood of
smallpox vaccine recipients. Vaccine 25: 4571–4574.
22. Savona MR, Dela Cruz WP, Jones MS, Thornton JA, Xia D, et al. (2006)
Detection of vaccinia DNA in the blood following smallpox vaccination. JAMA
295: 1898–1900.
23. de Souza Trindade G, Li Y, Olson VA, Emmerson G, Regnery R, et al. (2008)
Real-time PCR assay to identify variants of Vaccinia virus: implications for the
diagnosis of bovine vaccinia in Brazil. J Virol Methods 152: 63–71.
24. Marshall R, Chernesky M, Jang D, Hook EW, Cartwright CP, et al. (2007)
Characteristics of the m2000 automated sample preparation and multiplex real-
time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
J Clin Microbiol 45: 747–751.
25. Gonzalez A, Piqueres P, Moreno Y, Canigral I, Owen RJ, et al. (2008) A novel
real-time PCR assay for the detection of Helicobacter pullorum-like organisms in
chicken products. Int Microbiol 11: 203–208.
26. Watzinger F, Ebner K, Lion T (2006) Detection and monitoring of virus
infections by real-time PCR. Mol Aspects Med 27: 254–298.
27. Balinsky CA, Delhon G, Afonso CL, Risatti GR, Borca MV, et al. (2007)
Sheeppox virus kelch-like gene SPPV-019 affects virus virulence. J Virol 81:
11392–11401.
Avipoxvirus Real-Time PCR
PLoS ONE | www.plosone.org 6 May 2010 | Volume 5 | Issue 5 | e10745